Diabetic Neuropathy Collection: Treatment of Diabetic Neuropathy.

Diabetes Diabetic neuropathy Nerve damage Pain Type 1 diabetes Type 2 diabetes

Journal

Diabetes therapy : research, treatment and education of diabetes and related disorders

ISSN: 1869-6953

Titre abrégé: Diabetes Ther

Pays: United States

ID NLM: 101539025

Informations de publication

Date de publication:
Apr 2020

Historique:

received: 03 02 2020

pubmed: 11 3 2020

medline: 11 3 2020

entrez: 11 3 2020

Statut: ppublish

Résumé

Video: Treatment of Diabetic Neuropathy podcast recording (MP4 61908 kb).

Identifiants

DOI: 10.1007/s13300-020-00784-3 PMID: 32152931 PMC: PMC7136380

pubmed: 32152931

doi: 10.1007/s13300-020-00784-3

pii: 10.1007/s13300-020-00784-3

pmc: PMC7136380

doi:

Types de publication

Editorial

Langues

eng

Pagination

765-772

Références

UK D. Diabetes UK: facts & figures 2019. https://www.diabetes.org.uk/resources-s3/2019-02/1362B_Facts%20and%20stats%20Update%20Jan%202019_LOW%20RES_EXTERNAL.pdf . Accessed 17 Feb 2020.

Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabetes Care. 2011;34(10):2220–4.

doi: 10.2337/dc11-1108

Alam U, Jeziorska M, Petropoulos IN, et al. Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy. PLoS One. 2017;12(7):e0180175.

doi: 10.1371/journal.pone.0180175

Iqbal Z, Azmi S, Yadav R, et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther. 2018;40(6):828–49.

doi: 10.1016/j.clinthera.2018.04.001

Alam U, Sloan G, Tesfaye S. Treating pain in diabetic neuropathy: current and developmental drugs. Drugs. 2020. https://doi.org/10.1007/s40265-020-01259-2 .

doi: 10.1007/s40265-020-01259-2 pubmed: 32040849

Tesfaye S, Malik R, Harris N, et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia. 1996;39(3):329–35.

doi: 10.1007/BF00418349

Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain. 2015;138(Pt 1):43–52.

doi: 10.1093/brain/awu307

Bril V, England J, Franklin GM, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2011;76(20):1758–65.

doi: 10.1212/WNL.0b013e3182166ebe

Chou R, Carson S, Chan BKS. Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials. J Gen Intern Med. 2009;24(2):178–88.

doi: 10.1007/s11606-008-0877-5

Selvarajah D, Petrie J, White D, et al. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial. Trials. 2018;19(1):578.

doi: 10.1186/s13063-018-2959-y

Azmi S, ElHadd KT, Nelson A, et al. Pregabalin in the management of painful diabetic neuropathy: a narrative review. Diabetes Ther. 2019;10(1):35–56.

doi: 10.1007/s13300-018-0550-x

Gill D, Derry S, Wiffen PJ, Moore RA. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011;(10):CD009183.

Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005;96(6):399–409.

doi: 10.1111/j.1742-7843.2005.pto_96696601.x

Hearn L, Derry S, Phillips T, Moore RA, Wiffen PJ. Imipramine for neuropathic pain in adults. Cochrane Database System Rev. 2014;(5):CD010769.

Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;4:Cd005454.

Onali P, Dedoni S, Olianas MC. Direct agonist activity of tricyclic antidepressants at distinct opioid receptor subtypes. J Pharmacol Exp Ther. 2010;332(1):255–65.

doi: 10.1124/jpet.109.159939

Tesfaye S, Wilhelm S, Lledo A, et al. Duloxetine and pregabalin: high-dose monotherapy or their combination? The “COMBO-DN study”–a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain. 2013;154(12):2616–25.

doi: 10.1016/j.pain.2013.05.043

Rayman G, Baker NR, Krishnan ST. Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy. Diabetes Care. 2003;26(9):2697–8.

doi: 10.2337/diacare.26.9.2697-a

Viola V, Newnham HH, Simpson RW. Treatment of intractable painful diabetic neuropathy with intravenous lignocaine. J Diabetes Complic. 2006;20(1):34–9.

doi: 10.1016/j.jdiacomp.2005.05.007

Tesfaye S, Watt J, Benbow SJ, Pang KA, Miles J, MacFarlane IA. Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy. Lancet. 1996;348(9043):1698–701.

doi: 10.1016/S0140-6736(96)02467-1

Albers JW, Jacobson R. Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trials. Diabetes Metab Syndr Obes. 2018;11:493–514.

doi: 10.2147/DMSO.S146121

Bouhassira D, Wilhelm S, Schacht A, et al. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study. Pain. 2014;155(10):2171–9.

doi: 10.1016/j.pain.2014.08.020

Holbech JV, Bach FW, Finnerup NB, Brosen K, Jensen TS, Sindrup SH. Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial. Pain. 2015;156(5):958–66.

doi: 10.1097/j.pain.0000000000000143

Harada E, Tokuoka H, Fujikoshi S, et al. Is duloxetine’s effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials. Pain. 2016;157(3):577–84.

doi: 10.1097/j.pain.0000000000000406

Boyle J, Eriksson ME, Gribble L, et al. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care. 2012;35(12):2451–8.

doi: 10.2337/dc12-0656

Yoo M, D’Silva LJ, Martin K, et al. Pilot study of exercise therapy on painful diabetic peripheral neuropathy. Pain Med. 2015;16(8):1482–9.

doi: 10.1111/pme.12743

Kluding PM, Pasnoor M, Singh R, et al. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complic. 2012;26(5):424–9.

doi: 10.1016/j.jdiacomp.2012.05.007

Hameed S. Na(v)1.7 and Na(v)1.8: role in the pathophysiology of pain. Mol Pain. 2019;15:1744806919858801.

doi: 10.1177/1744806919858801

Alsaloum M, Estacion M, Almomani R, et al. A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy. Mol Pain. 2019;15:1744806919849802.

doi: 10.1177/1744806919849802